Approval · Notice of Compliance 17613 · 2015
LENVIMA: Notice of Compliance 17613
Issued December 22, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17613
- Date
- December 22, 2015
- Company
- Eisai LimitedWoodcliff Lake, New Jersey, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
Medicinal ingredients
- LENVATINIB MESYLATE 4 MG per CAP
- LENVATINIB MESYLATE 10 MG per CAP